How Clario automates clinical research analysis using generative AI on AWS

Clinical outcome assessment (COA) interviews are important instruments in clinical trials for evaluating the efficacy and safety of treatments. In studies of psychosis, anxiety, and mood disorders, these assessments often determine the success or failure of the trial, highlighting the importance of data quality and reliability. The traditional approach to evaluating the quality of these outcomes is complex and involves time-consuming, logistically challenging reviews of audio-video recordings in near real time. Interview evaluation variability, poor assessment technique, and other factors can introduce noise, leading to unreliable results and potentially to study failure.

About Clario

Clario is a leading provider of endpoint data solutions for systematic collection, management, and analysis of specific, pre-defined outcomes (endpoints) to evaluate a treatment’s safety and effectiveness in the clinical trials industry. Clario generates high-quality clinical evidence for life sciences companies seeking to bring new therapies to patients. Since its founding over 50 years ago ...